A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient with Type 2 Diabetes

计划入组 100 人 · 首次发布于 2024 年 2 月 13 日

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

计划入组 315 人 · 首次发布于 2024 年 7 月 3 日

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

计划入组 18 人 · 首次发布于 2023 年 10 月 23 日

Revity

REACTA

Benzalkonium(BZK Pads, Band-aid Hurt-free, Diphen, Revitaderm Wound Care)

Kerry Rogers

United States

Reviva Pharmaceuticals

United States

DaVita

United States

Fractyl Health's Revita System Receives FDA Breakthrough Device Designation for Weight Maintenance After GLP-1 Discontinuation

Fractyl Health's Revita Procedure Shows Promise in Sustained Weight Loss Management

Fractyl Health's Revita Shows Sustained Weight Loss and Improved Blood Sugar in Real-World Setting